According to filings with the U.S. Securities and Exchange Commission, Venatorx Pharmaceuticals is raising $16,350,000.00 in new funding. Sources indicate that as part of senior management President, Christopher Burns played a key role in securing…
Malvern, PA – According to filings with the U.S. Securities and Exchange Commission, Venatorx Pharmaceuticals is raising $24,466,240.00 in new funding. Sources indicate as part of senior management President, Christopher Burns played a key role…
Malvern, PA – According to filings with the U.S. Securities and Exchange Commission, VenatoRx Pharmaceuticals is raising $59,999,999.00 in new funding. Sources indicate as part of senior management President, Christopher Burns played a key role…